Approach

Our process provides your patients with an accelerated turnaround for personalized care.

CertaPath™ DST Process

Sample Collection

Drug Sensitivity Testing (DST)

Treatment Prioritization

Drug Sensitivity Testing (DST)

Drug Sensitivity Testing (DST) for Personalized
Treatment Planning Improves Survival Rates

  • Collection of material during standard-of-procedures allows for simple integration into clinical workflows
  • Actionable and straightforward screening reports facilitate rapid treatment planning

Drug Sensitivity Testing (DST) for Personalized
Treatment Planning Improves Survival Rates

Current stratification methods suffer from long turnover times and limited clinical utility.

Biocerta’s Ex vivo Drug Sensitivity 
Testing (DST) provides:

  • Collection of material during standard-of-procedures allows for simple integration into clinical workflows
  • Actionable and straightforward screening reports facilitate rapid treatment planning